Pritzker Hageman attorneys are helping patients who were harmed by this drug. Pradaxa (dabigatran), a blood thinner, has caused hundreds of deaths and serious injuries because it has no “antidote” to stop internal bleeding.
Pradaxa personal injury lawsuits may claim the drug caused a hemorrhagic stroke, gastrointestinal bleeding (esophagus, stomach, intestines, rectum), heart attack, or severe internal bleeding. Pradaxa wrongful death lawsuits claim that the internal bleeding caused a family member, generally an elderly parent, to bleed to death.
Our Lawyers Can Help You
Attorneys Fred Pritzker and David Szerlag have experience with these cases and are available for a free consultation regarding a lawsuit against Boehringer Ingelheim Pharmaceuticals Inc., the company that created Pradaxa, and others. This consultation will provide you the opportunity to discuss your case and ask questions about our experience and record of success. Fred and David were on our litigation team that won over $20,000,000 for clients injured by another medical product manufactured by another company.
Pradaxa and Internal Bleeding
Manufacturers of Pradaxa sold the drug knowing that it does not have an efficient reversal mechanism. Only two to three hours of dialysis can remove Pradaxa from the bloodstream and stop its blood-thinning effects, which is not enough time to prevent serious injury, and in some cases death, from internal bleeding. Warfarin, a similar-strength blood thinner, has an “antidote”, vitamin K. One dose of vitamin K will reverse warfarin’s blood-thinning effects and prevent serious injury or death from internal bleeding.
A recent medical study found that people over 80 are at greatest risk of serious injury or death from Pradaxa-related internal bleeding. In this group of patients, those with impaired kidney function, and weigh less than 132 pounds are most at risk.